Deutsche Bank Ag\ Oric Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 29,361 shares of ORIC stock, worth $300,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,361

Previous 25,325 15.94%

Holding current value

$300,950

Previous $348,000 40.52%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $26,758 - $52,185	4,036 Added 15.94%	29,361 $207,000
Q1 2024 May 15, 2024	BUY	$8.04 - $16.03 $4,413 - $8,800	549 Added 2.22%	25,325 $348,000
Q4 2023 Feb 14, 2024	SELL	$5.41 - $9.43 $5,231 - $9,118	-967 Reduced 3.76%	24,776 $227,000
Q3 2023 Nov 09, 2023	BUY	$6.05 - $9.28 $23,038 - $35,338	3,808 Added 17.36%	25,743 $155,000
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $15,998 - $27,148	-3,232 Reduced 12.84%	21,935 $170,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $31,824 - $52,939	-10,103 Reduced 28.64%	25,167 $81,000
Q2 2022 Aug 11, 2022	BUY	$2.7 - $7.07 $48,292 - $126,454	17,886 Added 102.89%	35,270 $158,000
Q1 2022 May 13, 2022	SELL	$4.54 - $16.1 $9,252 - $32,811	-2,038 Reduced 10.49%	17,384 $93,000
Q4 2021 Feb 11, 2022	SELL	$12.01 - $20.3 $29,808 - $50,384	-2,482 Reduced 11.33%	19,422 $285,000
Q3 2021 Nov 04, 2021	BUY	$15.9 - $25.22 $26,902 - $42,672	1,692 Added 8.37%	21,904 $458,000
Q2 2021 Aug 11, 2021	BUY	$17.37 - $25.34 $61,298 - $89,424	3,529 Added 21.15%	20,212 $358,000
Q1 2021 May 13, 2021	BUY	$23.67 - $36.85 $3,242 - $5,048	137 Added 0.83%	16,683 $408,000
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $237,317 - $464,824	11,679 Added 239.96%	16,546 $560,000
Q3 2020 Nov 12, 2020	BUY	$19.5 - $31.26 $8,229 - $13,191	422 Added 9.49%	4,867 $122,000
Q2 2020 Aug 13, 2020	BUY	$25.68 - $38.12 $114,147 - $169,443	4,445 New	4,445 $150,000

Others Institutions Holding ORIC

# of Institutions

112

Shares Held

63.1M

Call Options Held

Put Options Held

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account